Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for post-herpetic neuralgia (Phase 2, Portugal)
2007-002473-31Phase 2Completed
- Sponsor
- BIAL
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eslicarbazepine acetate in postherpetic neuralgia (PHN), sponsored by BIAL. Primary endpoint: Change in neuropathic pain intensity (post-herpetic origin). Started Jul 2007; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2007-002473-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002473-31.